Selinexor is a selective inhibitor of nuclear export, functioning as an antagonist of exportin 1 (XPO1) to treat relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma. Pharmaceutical… Read more


Selinexor is a selective inhibitor of nuclear export, functioning as an antagonist of exportin 1 (XPO1) to treat relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma. Pharmaceutical laboratories utilize high-quality reference standards of this compound, alongside its specific impurities, metabolites, and stable isotope-labelled derivatives, to support rigorous analytical testing. These compounds are essential for accurate impurity profiling, method validation, and ongoing quality control during the manufacturing process. By providing traceable reference materials that correspond to degradation products and synthetic intermediates, these standards ensure the precision required for testing raw materials and final drug products. Whether developing new analytical methods or performing routine batch release, researchers rely on these verified compounds to monitor for specific impurities and ensure compliance with regulatory standards for drug safety and efficacy.